Know Cancer

or
forgot password

Procurement of Follicular B Cell Lymphoma Cells From Blood, Tissue or Malignant Effusion for the Purpose of Possible Use in Future Clinical Trials: A Minimal Risk Protocol


N/A
35 Years
N/A
Open (Enrolling)
Both
Non-Hodgkin's Lymphoma

Thank you

Trial Information

Procurement of Follicular B Cell Lymphoma Cells From Blood, Tissue or Malignant Effusion for the Purpose of Possible Use in Future Clinical Trials: A Minimal Risk Protocol


- The following tests and procedures will be performed: Approximately 50cc of peripheral
blood will be drawn and stored in the tissue bank; patients who have follicular lymphoma
cells circulating in the blood will have about 40cc's of blood drawn and stored for
processing; patients undergoing a lymph node biopsy will have samples of the biopsy stored;
patients having fluid drained from the abdomen or from around the lung will have some of
their fluid saved to cell collection and processing; patients undergoing a bone marrow
biopsy will have some of the sample stored for cell collection and processing.


Inclusion Criteria:



- Relapsed, refractory or de novo histologically confirmed follicular B-cell lymphoma
with accessible lymph nodes, tumor mass or malignant effusion or peripheral blood

- 35 years of age or older

Exclusion Criteria:

- Uncontrolled active infection

- HIV or viral Hepatitis infection

- Other current malignancies except any in situ cancer or basal or squamous cell
carcinoma of the skin

- Autoimmune cytopenias

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

Eric Jacobsen, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Dana-Farber Cancer Institute

Authority:

United States: Institutional Review Board

Study ID:

06-276

NCT ID:

NCT00487513

Start Date:

June 2007

Completion Date:

June 2013

Related Keywords:

  • Non-Hodgkin's Lymphoma
  • Follicular B Cell lymphoma
  • vaccination
  • Lymphoma
  • Lymphoma, Non-Hodgkin
  • Lymphoma, B-Cell

Name

Location

Dana-Farber Cancer InstituteBoston, Massachusetts  02115